Recent trends in research on congenital toxoplasmosis

International Journal for Parasitology

Volumn 31, Issue 2, 2001, Pages 115-144

  Petersen, E ^a   Pollak, A ^a   Reiter Owona, I ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Diagnosis; HIV; Neonates; Prevalence; Toxoplasma gondii; Treatment

Indexed keywords

FANSIDAR; FOLINIC ACID; IMMUNOGLOBULIN M; SULFADIAZINE;

ANTIBODY DETECTION; CLINICAL FEATURE; CONGENITAL TOXOPLASMOSIS; DRUG EFFICACY; EUROPE; HUMAN; IMMUNOBLOTTING; NEWBORN SCREENING; PERINATAL DEVELOPMENT; PREVALENCE; REVIEW; TOXOPLASMA GONDII; TREATMENT INDICATION;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; RESEARCH; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

TOXOPLASMA GONDII;

EID: 0035111808     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(00)00140-5     Document Type: Review

References (128)

1. Toxoplasmosis in last four years in Aegean region, Turkey
2. Investigation of Toxoplasma antibodies in residence of central Izmir and surrounding
3. The activity of Atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine
4. Toxoplasmose em Sotalia guianensis (Van Beneden,1863), cetacea-delphinidae, importancia médico social
5. Oocyst-transmitted toxoplasmosis associated with ingestion of contaminated water
6. Diagnostic anténatal de la toxoplasmose. A propos de 176 observations
7. Outbreak associated with municipal drinking water
8. Detection of Toxoplasma gondii by competitive DNA amplification of bronchoalveolar lavage samples
9. Risk factors for recent Toxoplasma infection in pregnant women in Naples
10. Direct and sensitive detection of a pathogenic protozoan. Toxoplasma gondii, by polymerase chain reaction
11. Considerations sur 23 cas de choriorethinite chez des sujets adultes porteurs d'anticorps toxoplasmiques
12. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study
13. Le diagnostic anténatal de toxoplasmose. Aspects récents de la biologie
14. Clinical experience from the epidemic of toxoplasmosis in Southern Moravia in 1993-1994
15. Some aspects of the epidemiology of toxoplasmosis and pneumocystosis in AIDS in Europe
16. Isolation of Toxoplasma from the soil during an outbreak of toxoplasmosis in a rural area in Brazil
17. Outbreak of human toxoplasmosis in a rural area. A three year serologic follow-up study
18. Toxoplasmose congénitale. Prise en charge et devenir
19. Etude d'une série homogène de 210 cas de toxoplasmose congénitale chez des nourrissons âgé de 0 à 11 mois et dépistés de façon prospective
20. Le pronostic oculaire de la toxoplasmose congénitale: Role du traitement
21. Foetopathie toxoplasmique
22. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine
23. Prevalence of Toxoplasma infection and incidence of maternal infection in pregnant women
24. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii
25. A family outbreak of toxoplasmosis: A serendipitous finding
26. An IgM immunosorbent agglutination assay for diagnosis of infectious diseases: Diagnostic of acute congenital and acquired Toxoplasma infections
27. Antenatal screening for toxoplasmosis
28. Serological rebounds after one-year-long treatment for congenital toxoplasmosis
29. Characterization of Toxoplasma gondii isolates from an outbreak of toxoplasmosis in Atlanta Georgia
30. Assesment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting Toxoplasma specific IgM
31. European collaborative study. Low incidence of Toxoplasma infection in children born to women infected with human immunodeficiency virus
32. Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counselling
33. Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS
34. Correlation between ELISA, IFA and IHA techniques in the diagnosis of toxoplasmosis
35. An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii
36. Changes in the personality profile of young women with latent toxoplasmosis
37. The role of psychological factors in questionnaire-based studies on route of human toxoplasmosis transmission: The raw meat consumption but not the contact with cats seems to be a major risk factor
38. Clinical and serological rebounds in infants with congenital toxoplasmosis: Follow-up during the first 2 years of life
39. Treatment of toxoplasmosis during pregnancy: A multicenter study of impact on fetal transmission and children's sequelae at age 1 year
40. Transmission of Toxoplasma gondii in Panama city. Panama: A five-year prospective cohort study of children, cats, rodents, birds and soil
41. Toxoplasmose congénitale: Apport du suivi biologique postnatal
42. Toxoplasmose: Aspects nouveaux dans la surveillance de la femme enceinte et du nouveau-né
43. Sources of Toxoplasma infection in pregnant women: A European multicentre case-control study
44. An unusually high prevalence of ocular toxoplasmosis in Southern Brazil
45. Follow-up of infants with congenital toxoplasmosis detected by polymerases chain reaction analysis of amniotic fluid
46. Identification of a virulent-associated antigen of Toxoplasma gondii by use of a mouse monoclonal antibody
47. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection
48. Interlaboratory comparison of PCR for the detection of Toxoplasma gondii in samples of artificially infected amniotic fluid
49. Prevalence of antibodies against Toxoplasma gondii in blood donors in 1980-1990
50. Prevalence of toxoplasmosis in pigs in the region of South Bohemia
51. Prevalence of toxoplasmosis in rabbits in South Bohemia
52. Antibodies against Toxoplasma gondii in pregnant women of the ceské budojovice
53. Toxoplasma health education in Europe
54. Detection of Toxoplasma gondii oocysts in drinking water
55. Pathogenesis and pathological anatomy of the so-called coloboma of the yellow spot in a patient with normal and microphthalmic eyes with finding of parasites in the retina
56. Results of the Toxoplasma- intradermal test in the so-called normal population in Czechoslovakia
57. Absence of antibodies to HIV-2/HTLV-4 in six central African nations
58. An epidemic of acute toxoplasmosis
59. Results of 20 year follow-up of congenital toxoplasmosis
60. The immunology of Toxoplasma and toxoplasmosis
61. Relationship of anti-Toxoplasma antibodies with urban or rural settlement feeding habits and domestic animals
62. Comparison of different commercial diagnostic kits in detection of anti-toxoplasmosis IgM antibodies in the diagnosis of acute toxoplasmosis
63. Congenital Toxoplasmosis
64. Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark
65. Classification system and case definitions of Toxoplasma-infections in immunocompetent pregnant women and their congenitally infected offspring
66. Feasibility of neonatal screening for Toxoplasma infection in the absence of prenatal treatment
67. Restriction fragment length polymorphism and virulence of Czech Toxoplasma gondii strains
68. The mortality and pathology of HIV infection in a west African city
69. Toxoplasmosis
70. Three children with congenital toxoplasmosis: Early report from a Swedish prospective screening study
71. Laboratory epidemic of toxoplasmosis
72. Estudo da uveite e seu tratamento
73. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago collaborative treatment trial
74. An outbreak of toxoplasmosis in pregnant women in northern Québec
75. Immunogenetics in pathogenesis of and protection against toxoplasmosis
76. Peculiarities of ocular toxoplasmosis in Rio Grande do Sul
77. Epidemiology of ocular toxoplasmosis in Rio Grande do Sul, Brazil
78. Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation
79. Sur une infection a corps de leshmen (ou organismes voisins) du gondii
80. Sur une prozaire nouveau du gondii (Toxoplasma n.g)
81. Toxoplasmosis and chorioretinitis in Nigeria
82. Antibodies to Toxoplasma gondii in a rat-eating population of Benue state
83. Toxoplasmose
84. Active control of congenital toxoplasmosis in the population
85. Neonatal screening for Toxoplasma gondii in Poznan region (Poland)
86. Congenital toxoplasmosis in the Poznan region. [Polish]
87. A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams
88. Reacoes de sabin-feldman e de wassermann em pacientes com uveite
89. Performance of European laboratories testing serum samples for Toxoplasma gondii
90. A tween-ether preparation of Toxoplasma gondii antigen for the complement fixation test
91. A recommendation for standardisation of a micromethod of complement fixation for serum diagnosis of toxoplasmosis
92. Assessment of antitoxoplasmic IgG by the ELISA method
93. Assessment of antitoxoplasmic IgM by the ELISA method
94. Parasitic opportunistic infections in Czech HIV-infected patients: A prospective study
95. Fetal diagnosis of toxoplasmosis in 190 women infected during pregnancy
96. Employment of ELISA and direct immunofluorescence tests for diagnosing an outbreak of toxoplasmosis
97. Nonimmunological factors affecting the release of excreted/secreted antigens from Toxoplasma gondii cysts
98. The probability of acquiring primary Toxoplasma infection in HIV-infected patients: Results of an 8-year retrospective study
99. Looking back on half a century of the Sabin-Feldman dye-test: Its past and present role in the serodiagnosis of toxoplasmosis. Results of an European multicentre study
100. Seroprevalance of toxoplasmosis in Fortaleza Ceara, Brazil.
101. Toxoplasma gondii: Role of the phosphatidylcholine-specific phospholipase C during cell invasion and intracellular development
102. Neurologic and developmental outcome in treated congenital toxoplasmosis
103. Untersuchungen von neugeborenen und fetalseren zur erfassung von konnatalen Toxoplasma-infektionen
104. Toxoplasmosis infection associated with raw goat's milk
105. Calculation of the frequency of primary toxoplasmosis-infection in pregnancy and congenital toxoplasmosis
106. Phenylalanine derivates active against Toxoplasma gondii brain cysts in mice
107. Investigation of the prevalance of Toxoplasma gondii antibodies in the sera of mother and cord blood
108. Results of serological examination for toxoplasmosis in various groups of the Czechoslovak population
109. Epidemiology of toxoplasmosis
110. Epidemiological aspects of toxoplasmosis in school children residing in localities with urban or rural characteristics within the city of Rio de Janeiro, Brazil
111. Un nuovo protozoa parasite de conigli
112. An outbreak of toxoplasmosis linked to cats
113. Treatment of toxoplasmosis in the pregnant mother and newborn child
114. Prevalence of IgM and IgG antibodies to Toxoplasma gondii in blood donors in the Czech Republic
115. Toxoplasmic antibodies in sera of HIV-infected persons
116. Epidemic toxoplasmosis associated with infected cats
117. A new agglutination test for diagnosis of acute and chronic Toxoplasma infection
118. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: Follow-up of 78 cases between 1980 and 1997
119. Congenital toxoplasmosis: Systematic review of evidence of efficacy of treatment in pregnancy
120. Structural changes of Toxoplasma gondii bradyzoites and cysts following therapy with sulfamethoxypyrazine-pyrimethamine: Studies by light and electron microscopy consequences for chemotherapy
121. Development of adverse sequellae in children born with subclinical Toxoplasma infection
122. Prevention of the congenital toxoplasmosis